CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
Title:
CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
Author:
Johnson, Shawn F. Cruz, Cristina Greifenberg, Ann Katrin Dust, Sofia Stover, Daniel G. Chi, David Primack, Benjamin Cao, Shiliang Bernhardy, Andrea J. Coulson, Rhiannon Lazaro, Jean-Bernard Kochupurakkal, Bose Sun, Heather Unitt, Christine Moreau, Lisa A. Sarosiek, Kristopher A. Scaltriti, Maurizio Juric, Dejan Baselga, José Richardson, Andrea L. Rodig, Scott J. D’Andrea, Alan D. Balmaña, Judith Johnson, Neil Geyer, Matthias Serra, Violeta Lim, Elgene Shapiro, Geoffrey I.